ScoreWhy is CanSino Biologics, Inc. ?
1
Weak Long Term Fundamental Strength with a 12.76% CAGR growth in Operating Profits over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -60.98
2
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -42.13%, its profits have risen by 97.1%
3
Underperformed the market in the last 1 year
- Even though the market (Hang Seng Hong Kong) generated negative returns of -4.77% in the last 1 year, its fall in the stock was much higher with a return of -42.13%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is CanSino Biologics, Inc. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
CanSino Biologics, Inc.
-35.48%
0.53
66.95%
Hang Seng Hong Kong
-5.07%
-0.26
18.70%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
16.10%
EBIT Growth (5y)
12.76%
EBIT to Interest (avg)
-8.24
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.23
Sales to Capital Employed (avg)
0.14
Tax Ratio
12.96%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.25%
ROE (avg)
4.54%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.53
EV to EBIT
-18.38
EV to EBITDA
43.42
EV to Capital Employed
0.42
EV to Sales
1.55
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-2.28%
ROE (Latest)
-0.12%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
OPERATING CASH FLOW(Y)
Highest at HKD -141.63 MM
ROCE(HY)
Highest at 0.8%
NET SALES(Q)
At HKD 623.17 MM has Grown at 55.08%
OPERATING PROFIT MARGIN(Q)
Highest at 11.81 %
RAW MATERIAL COST(Y)
Fallen by -29.64% (YoY
DEBTORS TURNOVER RATIO(HY)
Highest at 1.48 times
PRE-TAX PROFIT(Q)
At HKD -5.56 MM has Grown at 74.68%
NET PROFIT(Q)
At HKD -4.56 MM has Grown at 72.7%
-3What is not working for the Company
CASH AND EQV(HY)
Lowest at HKD 2,132.48 MM
DEBT-EQUITY RATIO
(HY)
Highest at -17.37 %
INTEREST(Q)
Highest at HKD 39.97 MM
Here's what is working for CanSino Biologics, Inc.
Net Sales
At HKD 623.17 MM has Grown at 55.08%
Year on Year (YoY)MOJO Watch
Near term sales trend is very positive
Net Sales (HKD MM)
Operating Profit Margin
Highest at 11.81 % and Grown
In each period in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Operating Cash Flow
Highest at HKD -141.63 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (HKD MM)
Pre-Tax Profit
At HKD -5.56 MM has Grown at 74.68%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (HKD MM)
Net Profit
At HKD -4.56 MM has Grown at 72.7%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is positive
Net Profit (HKD MM)
Debtors Turnover Ratio
Highest at 1.48 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -29.64% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
At HKD 111.13 MM has Grown at 6.85%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (HKD MM)
Here's what is not working for CanSino Biologics, Inc.
Interest
Highest at HKD 39.97 MM
in the last five periods and Increased by 59.66% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (HKD MM)
Cash and Eqv
Lowest at HKD 2,132.48 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -17.37 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Non Operating Income
Highest at HKD 7.11 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income
Footer loading
